Integration of Research & Innovation and Business strategies

Size: px
Start display at page:

Download "Integration of Research & Innovation and Business strategies"

Transcription

1

2 Integration of Research & Innovation and Business strategies Dr. Fred van Ommen CEO Bizz Innovation Group (former SVP Innovation & Strategy Philips Group Innovation) Bizz Innovation Group

3 RESEARCH is turning money into ideas. 3

4 INNOVATION is turning ideas into money 4

5 Change is the key driver of business creation We cannot solve our problems with the same thinking we used to created them 5 Albert Einstein 5

6 The Effectual Catalyst 6

7 Today s logic cannot to deal with the global trends: New ways of thinking and working are required Aging population/ Chronic diseases The rise of emerging markets Increased consumer/patient empowerment and (un) sustainable lifestyles Climate change and sustainable development

8 7 million adults die each year from Cancer 8 million people are newly diagnosed with tuberculosis every year and it remains a worldwide threat 17 million adults die each year from Cardiovascular Disease 24 million people worldwide are affected by Alzheimer's disease 285 million adults have diabetes 300 million people suffer from Asthma; more than 200 million have Chronic Obstructive Pulmonary Disease 8

9 It is getting worse. In US 75% of Healthcare costs are related to chronic diseases In China 70% of diseases are chronic diseases (260 million people) In China 85% of deaths are related to chronic diseases In China s big cities 20% of children between 7 17 are overweight/obese From number of obese people in emerging countries went from 250 million to 905 million (> x3) In 2020 emerging countries will spend 60% of their Healthcare budget on chronic diseases 9 9

10 Patient behavior and Pharma cost trend 50% of prescriptions are never filled 25 30% Of medicine are taken properly $290 billion Direct and indirect healthcare costs due to nonadherence (US) Pharma model is broken

11 Global Trends Requiring Disruptive Innovations Population growth China India United States Indonesia Brazil Pakistan Nigeria Bangladesh Russia Japan

12 Increasing needs 12

13 13

14 The logic of the business case today Global Trends Strategic Ambition Markets Categories Brand image Right To win Technology position Market position Business Case NPV, ROI. Opportunities 14

15 with Open Innovation your are no longer limited to your in house technology/market positions Global Trends Strategic Ambition Markets Categories Brand image Right To win Technology position Market position Business Case NPV, ROI. Opportunities 15

16 HeartStart Home Defibrillator 80% of the cardiac arrests occurs at home Brain death and permanent death start to occur in just 4 to 6 minutes Few attempts succeed after 10 minutes. Only 5% survives! No time to read the manual! Easy to use Specifically designed for use at home Life saver Making a difference 16

17 Disruptiveness to the customer determines how to innovate Global Trends Strategic Ambition Markets Categories Brand image Disruptive ness Existing vs New to world Right To win Technology position Market position Business Case NPV, ROI. Opportunities 17

18 Granularity of Innovation Market life cycle OUTSIDE IN Disruptiveness to consumer OUTSIDE IN New to the world New adjacent category New in the category Improved The Granularity of Innovation, A more granular perspective on innovation types driving enduring company performance. Granularity of Innovation is courtesy of Fred van Ommen (Bizz Innovation Group) Corina Kuiper (The Effectual Catalyst)

19 Two dimensions creating view on different types of innovation Existing category New category emerging Market life cycle (Segment/geo) growth mature Product Creation New Business Creation A map to the Innovation Jungle decline improved product new in category new new to adjacent world category New category Granularity of Innovation is courtesy of Fred van Ommen (Bizz Innovation Group) Corina Kuiper (The Effectual Catalyst) The Effectual Catalyst Disruptiveness (proposition is ) 19

20 . that enables different innovation perspectives From market share battle in existing spaces to opening new spaces Existing category New category Granularity of Innovation is courtesy of Fred van Ommen (Bizz Innovation Group) Corina Kuiper (The Effectual Catalyst) 20

21 Different types of business and business models Established business Product creation New business New Business Creation Recombine existing resources Mitigating risk Existing ecosystem Market share battle Customer insights known Leverage existing channels Established business models Focus on execution/leverage Short/mid term Existing organization Generate new opportunities Deal with the Unknowable New ecosystem Building mountains Changing customer behavior Building new channels New business models Learning / iterative Mid/long term New capabilities 21

22 4x4 innovation matrix for DSM 22

23 Conclusions Invention is turning money into ideas Innovation is turning ideas into money Disruptive innovation involves changing customer behavior, the ability to understand the customer will determine success or failure Innovation has many different forms, which can be mapped on the 4x4 Innovation matrix Plot your existing and new products into the different strategic areas of the innovation matrix for your strategic portfolio management Think BIG, act small, accelerate fast 23

24 Think BIG, act small, accelerate fast 24

Imaging Systems. Gene Saragnese CEO Imaging Systems

Imaging Systems. Gene Saragnese CEO Imaging Systems Growth from the Core: Imaging Systems Gene Saragnese CEO Imaging Systems Imaging g Markets 2009 Imaging Markets by Region Total EUR 14.2B 1700 900 350 1550 2300 Other emerging LATAM India Greater China

More information

News For Immediate Release

News For Immediate Release News For Immediate Release Contact: Gary Gatyas IMS Institute for Healthcare Informatics (610) 244-2600 ggatyas@us.imshealth.com IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly

More information

Moving from volume to value in the generic business model

Moving from volume to value in the generic business model Moving from volume to value in the generic business model CPhI Pre-connect conference Frankfurt 23rd October 2017 Copyright 2016 QuintilesIMS. All rights reserved. Key drivers to 2021 Global growth moderating

More information

Lighting Strategy. Key takeaways. We continue to grow at mid single digit and are taking decisive actions to address margin issues

Lighting Strategy. Key takeaways. We continue to grow at mid single digit and are taking decisive actions to address margin issues Lighting Strategy Frans van Houten a.i. CEO Philips Lighting 2 3 Key takeaways 24 1 Key takeaways 25 We have undertaken actions to address issues with our performance Results impacted by Slower market

More information

Four entry strategies for small and midsized companies

Four entry strategies for small and midsized companies White paper >7,100 sales reps >220 product launches in 20 countries supported since 2009 Emerging markets: Four entry strategies for small and midsized companies Executive summary Emerging markets offer

More information

Capturing the HealthTech opportunity

Capturing the HealthTech opportunity Capturing the HealthTech opportunity Frans van Houten, CEO Royal Philips JP Morgan European Capital Goods Conference June 11, 2015 Philips: strong starting positions in health and well-being Businesses

More information

Five macro-trends that are shaping the new competitive landscape!

Five macro-trends that are shaping the new competitive landscape! Five macro-trends that are shaping the new competitive landscape! Dr. Dominique Turpin President of IMD and the Nestlé Professor Swiss American Chamber of Commerce - Zurich, 22 April 2014 2015 - IMD International

More information

Valuing Healthcare Biotechnology in Europe: EuropaBio s perspective

Valuing Healthcare Biotechnology in Europe: EuropaBio s perspective Valuing Healthcare Biotechnology in Europe: EuropaBio s perspective The healthcare biotechnology sector The healthcare biotechnology sector includes bioscience based enterprises, which create and deliver

More information

Our Business and Brands

Our Business and Brands Our Business and Brands Advancing Sustainability in Green Buildings: Priorities & Provocations W. Scott Tew, Executive Director Center for Energy Efficiency and Sustainability $14+ billion diversified

More information

Press Information. From coal-mining to Life Sciences and Materials Sciences A history of successful transformation

Press Information. From coal-mining to Life Sciences and Materials Sciences A history of successful transformation Press Information DSM, Corporate Communications P.O. Box 6500, 6401 HJ Heerlen The Netherlands phone +31 (0) 45 578 2421 www.dsm.com From coal-mining to Life Sciences and Materials Sciences DSM has a long

More information

New Capitalism New Corporate Venturing

New Capitalism New Corporate Venturing 16 New Capitalism New Corporate Venturing MAXIMILIAN MARTIN to investments and resulting in products that power core business. But the pathways of sourcing business innovation now need updating in the

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India)

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) COPY Date : 23-02-2010 News / Story reproduced with thanks:- Stockmarkest.com Indian pharmaceutical industry has

More information

Problems of Poverty. Less Energy, Low Efficiency, Polluted Environment. Barun Mitra, Liberty Institute Brussels, 24 November 2004

Problems of Poverty. Less Energy, Low Efficiency, Polluted Environment. Barun Mitra, Liberty Institute   Brussels, 24 November 2004 Problems of Poverty Less Energy, Low Efficiency, Polluted Environment Barun Mitra, Liberty Institute www.libertyindia.org Brussels, 24 November 2004 India on the Energy Map Commercial energy production

More information

Chronic Care Update Coloplast Capital Markets Day 2016 Kristian Villumsen, EVP Chronic Care

Chronic Care Update Coloplast Capital Markets Day 2016 Kristian Villumsen, EVP Chronic Care Chronic Care Update Coloplast Capital Markets Day 2016 Kristian Villumsen, EVP Chronic Care Chronic Care represents the majority of Coloplast sales and has a #1 global position Chronic Care sales, in DKK

More information

Optum. One. Award-winning intelligent health analytics platform

Optum. One. Award-winning intelligent health analytics platform One Award-winning intelligent health analytics platform The One intelligent health platform enables health care providers to manage patient populations in a valuebased world. The platform combines the

More information

How to treat more patients and make money in emerging markets

How to treat more patients and make money in emerging markets 1 How to treat more patients and make money in emerging markets AUTHOR Raja Shankar RShankar@imscg.com People buy innovative products in emerging markets. Millions of Brazilians, Russians, Indians, Chinese,

More information

Challenges to Adopting Artificial Intelligence

Challenges to Adopting Artificial Intelligence Challenges to Adopting Artificial Intelligence Augmented Intelligence for Enterprise 17 November 2017 Drew Perez dperez@adatos.com Managing Director, Adatos A.I. Timing & Opportunity What Keeps CEOs Awake

More information

LEVERAGING BEHAVIORAL ECONOMICS IN HUMAN RESOURCES MANAGEMENT

LEVERAGING BEHAVIORAL ECONOMICS IN HUMAN RESOURCES MANAGEMENT LEVERAGING BEHAVIORAL ECONOMICS IN HUMAN RESOURCES MANAGEMENT J. David Johnson, MBA Vice President, Senior Consultant djohnson@sibson.com; 202.833.6482 Copyright 2015 by The Segal Group, Inc. All rights

More information

SBF Position Paper Megatrends shaping Singapore s Future Economic Strategies and Businesses Ng Siew Quan PwC Singapore

SBF Position Paper Megatrends shaping Singapore s Future Economic Strategies and Businesses Ng Siew Quan PwC Singapore www.pwc.com/sg SBF Position Paper Ng Siew Quan Megatrends shaping Singapore s Future Economic Strategies and Businesses Singapore What is a Megatrend? 1. Megatrends are macroeconomic forces that are shaping

More information

Market Analysis & Segmentation Bioshares Biotech Summit July Duncan Ross Managing Director & CEO

Market Analysis & Segmentation Bioshares Biotech Summit July Duncan Ross Managing Director & CEO Market Analysis & Segmentation Bioshares Biotech Summit July 2016 Duncan Ross Managing Director & CEO 1 Disclaimer This presentation has been prepared by AtCor Medical Holdings Limited (AtCor or the Company)solely

More information

Driving global scale and category leadership in Male Grooming. Caroline Clarke, CEO Personal Care

Driving global scale and category leadership in Male Grooming. Caroline Clarke, CEO Personal Care Driving global scale and category leadership in Male Grooming Caroline Clarke, CEO Personal Care 1 1 Key takeaways Our leadership position in Male Grooming is based on global scale and strong local relevance

More information

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President BD Strategy Overview Advancing the world of health Vincent A. Forlenza Chairman, Chief Executive Officer and President BD IS AT THE VERY BEGINNING OF AN AMAZING JOURNEY WHERE WE CAN HAVE A PROFOUND IMPACT

More information

Understanding How The Indian Pharmaceutical Industry Works Part 3

Understanding How The Indian Pharmaceutical Industry Works Part 3 Understanding How The Indian Pharmaceutical Industry Works Part 3 Key Performance Indicators Pharmaceutical Sector Sales & Marketing Marketing always starts with the customer and ends with the customer

More information

Pharmaceutical Innovation and Regulatory Data Protection Friends or Foes?

Pharmaceutical Innovation and Regulatory Data Protection Friends or Foes? Pharmaceutical Innovation and Regulatory Data Protection Friends or Foes? Meir Pugatch, EIPIN Meeting, Munich, April 2015 meir.pugatch@maastrichtuniversity.nl Presentation overview The value of pharmaceutical

More information

Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015

Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015 Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges

More information

Working Together for Better Health Partnering with Boehringer Ingelheim. JOURNEE COLLABORATIVE DE LYONBIOPOLE October 10, 2017

Working Together for Better Health Partnering with Boehringer Ingelheim. JOURNEE COLLABORATIVE DE LYONBIOPOLE October 10, 2017 Working Together for Better Health Partnering with Boehringer Ingelheim JOURNEE COLLABORATIVE DE LYONBIOPOLE October 10, 2017 Welcome to Partnering with Boehringer Ingelheim Our guiding principle Value

More information

Outline. Overview and Purpose. World Population. Indicators of Consumer Behavior The Market Basket Energy Transportation Travel Purchasing Power

Outline. Overview and Purpose. World Population. Indicators of Consumer Behavior The Market Basket Energy Transportation Travel Purchasing Power 1 Outline Overview and Purpose World Population Indicators of Consumer Behavior The Market Basket Energy Transportation Travel Purchasing Power Conclusion 2 Market Basket: Overview The Market Basket is

More information

Lesson Objectives. Students will be able to describe two main reasons why the world s population is rapidly increasing.

Lesson Objectives. Students will be able to describe two main reasons why the world s population is rapidly increasing. Population Lesson Objectives Students will be able to describe two main reasons why the world s population is rapidly increasing. Students will be able to explain some of the problems that rapid population

More information

Outline. Overview and Purpose. World Population. Indicators of Consumer Behavior The Market Basket Energy Transportation Travel Purchasing Power

Outline. Overview and Purpose. World Population. Indicators of Consumer Behavior The Market Basket Energy Transportation Travel Purchasing Power 1 Outline Overview and Purpose World Population Indicators of Consumer Behavior The Market Basket Energy Transportation Travel Purchasing Power Conclusion 2 Market Basket: Overview The Market Basket is

More information

Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint

Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint HIGH-LEVEL CONFERENCE "EXPLORING INNOVATIVE HEALTHCARE THE ROLE OF MEDICAL TECHNOLOGY INNOVATION AND REGULATION" Innovation in medical devices as response to Europe's healthcare challenges Industry's viewpoint

More information

Building growth momentum through personal health solutions. Roy Jakobs Chief Business Leader Personal Health

Building growth momentum through personal health solutions. Roy Jakobs Chief Business Leader Personal Health Building growth momentum through personal health solutions Roy Jakobs Chief Business Leader Personal Health Key takeaways Our leading Personal Health innovations enable healthier lifestyles and support

More information

Profitable growth strategies for the next 4 billion Learning from Indian Innovations

Profitable growth strategies for the next 4 billion Learning from Indian Innovations www.pwc.com Profitable growth strategies for the next 4 billion Learning from Indian Innovations 24-26 Content Growth Horizon (s) Emerging Middle Research Profitable Growth Strategies - Growth - Profit

More information

Global Sales and Service International. Kevin Haydon EVP and CEO Global Sales and Service International May 31st 2007

Global Sales and Service International. Kevin Haydon EVP and CEO Global Sales and Service International May 31st 2007 Global Sales and Service International Kevin Haydon EVP and CEO Global Sales and Service International May 31st 2007 Agenda Global Sales and Service International Business overview Opportunities in mature

More information

Trends and Transformations Facing Pharma in 2017

Trends and Transformations Facing Pharma in 2017 TH E Y E A R A H E A D : Trends and Transformations Facing Pharma in 2017 Table of Contents 2 Introduction Trend 1: The Rise of Generics Trend 2: Rx Volumes Spike Trend 3: Rise of Cold-Chain Logistics

More information

Margins of pharmaceutical companies are continuing to decline the future lies in new ecosystems

Margins of pharmaceutical companies are continuing to decline the future lies in new ecosystems Karin Mateu Media Relations Tel.: +41 (0) 58 286 44 09 karin.mateu@ch.ey.com Margins of pharmaceutical companies are continuing to decline the future lies in new ecosystems Glaxo is leading the way in

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 9.6.2004 COM(2004) 416 final Volume I COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE

More information

Lesson Objectives. Students will be able to describe two main reasons why the world s population is rapidly increasing.

Lesson Objectives. Students will be able to describe two main reasons why the world s population is rapidly increasing. Population Lesson Objectives Students will be able to describe two main reasons why the world s population is rapidly increasing. Students will be able to explain some of the problems that rapid population

More information

Winning in light sources. René van Schooten

Winning in light sources. René van Schooten Winning in light sources René van Schooten CEO Lamps business 94 Key takeaways The coming 5 years will bring significant opportunities We are uniquely positioned to capture the value in conventional light

More information

Nutrition and Food systems

Nutrition and Food systems Nutrition and Food systems A report by the High Level Panel of Experts on Food Security and Nutrition 10 October 2017 Jessica Fanzo HLPE Project Team Leader Outline of the report 1) Setting the scene:

More information

Agenda. Need Gap Analysis. Market Need and Our Approach. Business Model. Our Features. Unique Selling Proposition. Revenue Streams.

Agenda. Need Gap Analysis. Market Need and Our Approach. Business Model. Our Features. Unique Selling Proposition. Revenue Streams. A must for you Agenda Need Gap Analysis Market Need and Our Approach Business Model Our Features Unique Selling Proposition Revenue Streams What Do We Sell Roadmap Growth Plans Summary Accident Person

More information

The Battle of Big versus Small. Zenith Adspend Forecast 2017

The Battle of Big versus Small. Zenith Adspend Forecast 2017 The Battle of Big versus Small Zenith Adspend Forecast 2017 The global ad market will continue to grow steadily +5,9 Year-on-year growth (%) +5,6 +5,6 +5,5 +4,0 +4,1 +4,2 +4,1 2017 2018 2019 2020 Adspend

More information

GE Healthcare healthymagination Investor Update

GE Healthcare healthymagination Investor Update GE Healthcare healthymagination Investor Update UBS John Dineen President & CEO, GE Healthcare May 6, 2011 "Results are preliminary and unaudited. This document contains forward-looking statements - that

More information

Industry 4.0 building the digital survey results

Industry 4.0 building the digital survey results Industry 4.0 building the digital survey results Jesper Vedsø Email: jrv@pwc.dk Mobile: +45 21345307 Denmark 1 http://www.pwc.dk/da/industrier/produktion.html Agenda About the study Defining Industry 4.0

More information

The Climate Institute

The Climate Institute The Climate Institute Erwin Jackson, Deputy CEO Reflections on UNFCCC COP19 Melbourne University, 27 November 2013 Progress has been made since Copenhagen International climate change negotiations have

More information

NPO's Symposium By the People, For the People. Topic: Modern Fundraising Speaker: Kristofer Rogers

NPO's Symposium By the People, For the People. Topic: Modern Fundraising Speaker: Kristofer Rogers NPO's Symposium By the People, For the People Topic: Modern Fundraising Speaker: Kristofer Rogers Modern Fundraising Agenda: Modern Fundraising The Technology Revolution Technology for NPO s Simple Steps

More information

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania

More information

Health Care Business Group

Health Care Business Group Health Care Business Group Joaquin Delgado, Executive Vice President December 17, 2013 2013 3M. All Rights Reserved. 2 3M CONFIDENTIAL 2013 3M. All Rights Reserved. Saving and improving lives around the

More information

Financial Information

Financial Information Financial Information of 4.9 billion in Q1 2011, Continued strong organic at +12% Industry continued on a very solid momentum IT and Buildings expanded at double-digit thanks to solutions Power also solid,

More information

The need for generic policies as part of health reform

The need for generic policies as part of health reform The need for generic policies as part of health reform Richard Laing EMP/WHO for PPRI Conference Vienna September 30 th 2011 The US Generics Market reaches $107.5bn with growth four times higher than total

More information

THE ECONOMIC CONSEQUENCES OF OUTDOOR AIR POLLUTION

THE ECONOMIC CONSEQUENCES OF OUTDOOR AIR POLLUTION THE ECONOMIC CONSEQUENCES OF OUTDOOR AIR POLLUTION Elisa Lanzi OECD Environment Directorate FEEM Venice, September 1 2016 Structure of the presentation OECD s CIRCLE project Overview of the air pollution

More information

What s next for pharma in emerging markets?

What s next for pharma in emerging markets? Amit Agarwal, Julio Dreszer, and Jean Mina What s next for pharma in emerging markets? Pharmaceuticals & Medical Products June 2017 Succeeding in emerging markets has been a challenging undertaking for

More information

humanizing UN s Special Representative for Sustainable Energy for All focuses on the social dimension Interview by Alison Buckholtz

humanizing UN s Special Representative for Sustainable Energy for All focuses on the social dimension Interview by Alison Buckholtz humanizing UN s Special Representative for Sustainable Energy for All focuses on the social dimension Photo Micaela Ayala V/ Agencia Andes 6 IFC.ORG/HANDSHAKE Interview by Alison Buckholtz INTERVIEW Kandeh

More information

Marketing Strategy. Egbert van Acht CMO Philips Consumer Lifestyle

Marketing Strategy. Egbert van Acht CMO Philips Consumer Lifestyle Marketing Strategy Egbert van Acht CMO Philips Consumer Lifestyle The economic downturn is impacting demand in Consumer Lifestyle s mature markets All figures given as percentages 06- YTD Sep 08, percent

More information

Leveraging Big Data for Better Health Outcomes: The Need for a Collaborative Space and Common Solutions

Leveraging Big Data for Better Health Outcomes: The Need for a Collaborative Space and Common Solutions Leveraging Big Data for Better Health Outcomes: The Need for a Collaborative Space and Common Solutions Author: Richard Bergstrom * Date: 14.11.2016 * Version: 1 Disruption 2 Why this discussion now Definitions.

More information

The EU and Air Quality protecting health & environment

The EU and Air Quality protecting health & environment The EU and Air Quality protecting health & environment Zagreb, Croatia 30 May 2011 Anne Stauffer, anne@env-health.org Health & Environment Alliance, www.env-health.org Overview of presentation About HEAL

More information

2015 Business Overview

2015 Business Overview 2015 Business Overview a year of accomplishment www.mgcdiagnostics.com Table of Contents 01 Introduction 02 Message to Shareholders 03 Board and Management Team Our Identity 03 Shareholders Letter 04 Long-Range

More information

Industry Outlook. Chris Policinski. Annual Convention, San Francisco. March 19, Land O Lakes

Industry Outlook. Chris Policinski. Annual Convention, San Francisco. March 19, Land O Lakes Industry Outlook National Grain and Feed Association Annual Convention, San Francisco March 19, 2013 Chris Policinski President and CEO Land O Lakes Agenda Land O Lakes Overview Unprecedented Global Growth

More information

PhRMA Days Press Conference

PhRMA Days Press Conference PhRMA Days Press Conference April 12, 2017 Joaquin Duato Chairman of the Board, PhRMA Roadmap I. Recent Developments in the United States II. Biopharmaceutical Industry s Contribution to Innovation and

More information

Product Profit Management: The Key Lever of Operational Effectiveness Improvement

Product Profit Management: The Key Lever of Operational Effectiveness Improvement www.pwccn.com Product Profit Management: The Key Lever of Operational Effectiveness Improvement Introduction Why should we talk about product profit? It is due to the headwind against manufacturing industry

More information

HPC: Delivering sustained profitable growth

HPC: Delivering sustained profitable growth HPC: Delivering sustained profitable growth Ralph Kugler President HPC London March 13 th 2007 Safe harbour statement This presentation may contain forward-looking statements, including forward-looking

More information

Bridging the Transition Gap

Bridging the Transition Gap Bridging the Transition Gap Building a Symbiotic Relationship between SBIR Firms and Technology Seekers Beyond SBIR Phase II August 21, 2007 Joanne Hyland Founding Partner Radical Innovation Group Former

More information

DSM perspective on Innovation-driven growth

DSM perspective on Innovation-driven growth DSM perspective on Innovation-driven growth Henk Noorman Corporate Scientist BE-Basic Innovation Workshop 18-10-2011 Overview Innovation progress DSM Bio-based Products & Services DSM Biomedical Open innovation

More information

JP Morgan Global Healthcare Conference

JP Morgan Global Healthcare Conference JP Morgan Global Healthcare Conference January 12, 2016 Robert Friel, Chairman and CEO Factors affecting future performance & non-gaap financial measures This presentation contains "forward-looking" statements

More information

Children are breathing dirty air and parents are being left to fix it

Children are breathing dirty air and parents are being left to fix it Children are breathing dirty air and parents are being left to fix it Clean Air for Children is a new parent-led programme to tackle air pollution near schools. When will the government act too? Photograph:

More information

Vision and Strategic Research Agenda

Vision and Strategic Research Agenda Vision and Strategic Research Agenda For more information on the ETP, visit our website http://etp.ciaa.eu Vision and Strategic Research Agenda Food for Life The European Technology Platform 1 Food for

More information

Constructing Healthy China: Sharing, Innovation & Sustainable Development

Constructing Healthy China: Sharing, Innovation & Sustainable Development Constructing Healthy China: Sharing, Innovation & Sustainable Development 3 / 1/2017 Table of Contents Chapter One: Healthy China 2030...3 1. Healthy China 2030 is the first long-term national strategy

More information

Reducing Emissions from Deforestation and forest Degradation (REDD): Will Trees Grow on Money?

Reducing Emissions from Deforestation and forest Degradation (REDD): Will Trees Grow on Money? Reducing Emissions from Deforestation and forest Degradation (REDD): Will Trees Grow on Money? Frances Seymour Director General Center for International Forestry Research (CIFOR) Bogor, May 12, 2008 Presentation

More information

Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam

Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam Speech Nancy McKinstry Annual General Meeting of Shareholders 2008 April 22, 2008 Okura Hotel Amsterdam Welcome and good morning. It is a pleasure to be here today to share our 2007 results and provide

More information

Big Decisions: Using data and analytics to transform decisionmaking in Healthcare and Life Sciences

Big Decisions: Using data and analytics to transform decisionmaking in Healthcare and Life Sciences Big Decisions: Using data and analytics to transform decisionmaking in Healthcare and Life Sciences Insights from s Big Decisions TM Research November 2016 s Global Data and Analytics Survey 2016: Big

More information

Conversations with Unilever

Conversations with Unilever Conversations with Unilever Business has driven economic growth throughout the world over the past hundred years. The way we live today and have been living over the past hundred years is unsustainable.

More information

New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation

New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation Dr. Klaus Suwelack Johnson & Johnson Innovation, Janssen-Cilag Germany, Neuss

More information

HCP ENGAGEMENT REPORT: HOW TO MAXIMIZE MARKETING ROI

HCP ENGAGEMENT REPORT: HOW TO MAXIMIZE MARKETING ROI HCP ENGAGEMENT REPORT: HOW TO MAXIMIZE MARKETING ROI HCP ENGAGEMENT REPORT: HOW TO MAXIMIZE MARKETING ROI Digital technology is changing healthcare fast, opening a new, digital world for pharma marketers

More information

Internet of Health Things Survey

Internet of Health Things Survey DIGITAL HEALTH Internet of Health Things Survey Invest Today to Grow Tomorrow OVERVIEW...2 REMOTE PATIENT MONITORING...11 WELLNESS AND PREVENTION...16 OPERATIONS...20 RECOMMENDATIONS...24 DEFINITIONS...25

More information

Rural Livelihoods Case Study Nestlé and Novartis:

Rural Livelihoods Case Study Nestlé and Novartis: Rural Livelihoods Case Study Nestlé and Novartis: Collaborating to make rural areas more attractive places to live, work, and invest 2 Rural Livelihoods Case Study The big picture More than 3.3 billion

More information

smarter solutions better adherence improved results

smarter solutions better adherence improved results smarter solutions better adherence improved results Medication non-adherence is a big problem Costs the healthcare system roughly $300 billion Prescription Adherence Rates Significant drop in adherence

More information

Anesthesia and Respiratory Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,

Anesthesia and Respiratory Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Transparency Market Research Anesthesia and Respiratory Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Buy Now Request Sample Published Date: Oct 2013 Single

More information

Developing Drugs for Rare Diseases: Patient Advocacy s Perspective. Kristina Bowyer Executive Director, Patient Advocacy

Developing Drugs for Rare Diseases: Patient Advocacy s Perspective. Kristina Bowyer Executive Director, Patient Advocacy Developing Drugs for Rare Diseases: Patient Advocacy s Perspective Kristina Bowyer Executive Director, Patient Advocacy February 5, 2018 An Advocacy Perspective Why develop drugs for Rare Disease? What

More information

CCTG initiative. patient reported outcomes (including wearables)

CCTG initiative. patient reported outcomes (including wearables) Executive Summary Canada can be a global leader in the next generation of pharmaceutical and cancer care innovation. The Canadian Cancer Trials Group (CCTG) is requesting $39 million in federal funding

More information

Molecular Diagnostics at the Point of Need

Molecular Diagnostics at the Point of Need Molecular Diagnostics at the Point of Need 24 November 2016 David Budd CEO d.budd@genedrive.com 1 DOCUMENT INFORMATION The information contained in this document and made verbally to you (together the

More information

Big Data What's possible? What's not? What's Next? Sophia Van Big Data & Smart Analytics Lead Asia Oct 2015

Big Data What's possible? What's not? What's Next? Sophia Van Big Data & Smart Analytics Lead Asia Oct 2015 Big Data What's possible? What's not? What's Next? Sophia Van Big Data & Smart Analytics Lead Asia Oct 2015 Where are we and where are we going? Swissnex risk dialogue Matthias Weber 15 April 2015 2 What

More information

Heart and Stroke Foundation of Nova Scotia

Heart and Stroke Foundation of Nova Scotia Heart and Stroke Foundation of Nova Scotia 2005 HAVING AN IMPACT Canadian Institute for Economic Evaluation February 6 to 9 th Clare O Connor Director, Policy and Government Relations Context Among highest

More information

Entertainment and media outlook South Africa, Nigeria, Kenya

Entertainment and media outlook South Africa, Nigeria, Kenya www.pwc.co.za/outlook Entertainment and media outlook 2015-2019 South Africa, Nigeria, Kenya Beyond digital: empowered consumers demand choice and convenience that transcend platforms Charles Stuart www.pwc.co.za/outlook

More information

Anesthesia Devices Market and Respiratory Devices Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast:

Anesthesia Devices Market and Respiratory Devices Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast: Transparency Market Research Anesthesia Devices Market and Respiratory Devices Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast: 2013-2019 Buy Now Request Sample Published Date:

More information

Paul Smit Philips Healthcare February 6 th, 2008

Paul Smit Philips Healthcare February 6 th, 2008 Paul Smit Philips Healthcare February 6 th, 2008 Forward Looking Statements Forward Looking Statements This document and the related oral presentation, including responses to questions following the presentation

More information

Bridging the Generation Gap

Bridging the Generation Gap Bridging the Generation Gap Building a Symbiotic Relationship between Startups and Established Companies Cleantech Partnership Meeting 27 May 2009 Energy Infrastructure Transportation Waste and Wastewater

More information

WELCOME TO THE 23 rd ANNUAL SHAREHOLDER MEETING, SAP AG SAP AG. All rights reserved. / Page 1

WELCOME TO THE 23 rd ANNUAL SHAREHOLDER MEETING, SAP AG SAP AG. All rights reserved. / Page 1 WELCOME TO THE 23 rd ANNUAL SHAREHOLDER MEETING, SAP AG 2010 SAP AG. All rights reserved. / Page 1 BILL McDERMOTT CO-CEO, SAP AG 2010 SAP AG. All rights reserved. / Page 2 2009: YEAR OF CHANGE The New

More information

Frost & Sullivan independent analysis indicates that the market is slowly being eroded by several factors listed below.

Frost & Sullivan independent analysis indicates that the market is slowly being eroded by several factors listed below. Customer Service Leadership Award Early Intervention and Wellness North America, 2013 Frost & Sullivan s Global Research Platform Frost & Sullivan is in its 50th year in business with a global research

More information

70% not diagnosed, 75% not treated Many die in childhood or grow-up severely disabled

70% not diagnosed, 75% not treated Many die in childhood or grow-up severely disabled Economic Reality and the Development of Haemophilia Care Brian O Mahony, CEO Irish Haemophilia Society Esfahan, Iran April 2009 1 Haemophilia Care Globally 70% not diagnosed, 75% not treated Many die in

More information

WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT

WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT Pharmaceutical IP Policy Issues Economics - Business Model IP TPP Global Challenges

More information

A Benefits Partner You Can Be Confident In

A Benefits Partner You Can Be Confident In A Benefits Partner You Can Be Confident In Your company is unique. So are its employees and financial goals. Traditional, fully-insured health plans aren t always designed with your company s needs in

More information

Clean Air Health Benefits from Climate Change Mitigation Action George D. Thurston

Clean Air Health Benefits from Climate Change Mitigation Action George D. Thurston Clean Air Health Benefits from Climate Change Mitigation Action George D. Thurston Professor NYU School of Medicine New York, NY USA http://www.med.nyu.edu/biosketch/gdt1 @ProfGThurston Overview The Health

More information

Pharma R&D and Patents support Health Care & Economy

Pharma R&D and Patents support Health Care & Economy Pharma R&D and Patents support Health Care & Economy Konstantinos Μ. Frouzis President of SFEE, V.P & Gen. Manager of Novartis Hellas April 28 th, 2014 Intellectual Property Patents: The vehicle for innovation

More information

February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees)

February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees) February 25, 2019 (Monday) 8:30-16:30 Hrs BioPark Visit (Only for Invitees) 18:00-19:30 Hrs Inauguration of the 16 th BioAsia Convention Presentation of Genome Valley Excellence Award 19:30-20:00 Hrs Inauguration

More information

Project Management: Health Information Technology (HIT) Sustainability Beyond Go Live Scott Coplan, President COPLAN AND COMPANY

Project Management: Health Information Technology (HIT) Sustainability Beyond Go Live Scott Coplan, President COPLAN AND COMPANY Project Management: Health Information Technology (HIT) Sustainability Beyond Go Live Scott Coplan, President COPLAN AND COMPANY 1 Healthcare Crisis* The Institute of Medicine (IOM) stated 44 to 98 thousand

More information

October 2018 CL 160/10 COUNCIL. Hundred and Sixtieth Session. Rome, 3-7 December Proposal for an International Year of Fruits and Vegetables

October 2018 CL 160/10 COUNCIL. Hundred and Sixtieth Session. Rome, 3-7 December Proposal for an International Year of Fruits and Vegetables October 2018 CL 160/10 E COUNCIL Hundred and Sixtieth Session Rome, 3-7 December 2018 Proposal for an International Year of Fruits and Vegetables This document can be accessed using the Quick Response

More information

Tan Suan Phon Managing Director Inchcape China

Tan Suan Phon Managing Director Inchcape China Tan Suan Phon Managing Director Inchcape China Market Overview Population 1.34bn Language Mandarin Currency Chinese yuan (renminbi RMB) ( ) Capital City Beijing GDP US 5.9 trillion Source: IMF Since the

More information

BRIDGING THE GAP BETWEEN MEDICAL DISCOVERIES AND IMPROVED HEALTH AUSTRALIA TRANSLATIONAL RESEARCH INSTITUTE.

BRIDGING THE GAP BETWEEN MEDICAL DISCOVERIES AND IMPROVED HEALTH AUSTRALIA TRANSLATIONAL RESEARCH INSTITUTE. BRIDGING THE GAP BETWEEN MEDICAL DISCOVERIES AND IMPROVED HEALTH TRANSLATIONAL RESEARCH INSTITUTE www.tri.edu.au AUSTRALIA THE TRI WAY The Translational Research Institute (TRI) is where science, medicine

More information

NORDIC LIFE SCIEN SWEDEN S LIFE SCIENCE STRATEGY ANTIBIOTIC RESISTANCE THE LEADING LIFE SCIENCE BUSINESS MAGAZINE 169 SEK / 20 EUR / 25 USD

NORDIC LIFE SCIEN SWEDEN S LIFE SCIENCE STRATEGY ANTIBIOTIC RESISTANCE THE LEADING LIFE SCIENCE BUSINESS MAGAZINE 169 SEK / 20 EUR / 25 USD NORDIC LIFE SCIEN THE LEADING LIFE SCIENCE BUSINESS MAGAZINE 169 SEK / 20 EUR / 25 USD // UMEÅ // KUOPIO // TROMSØ ANTIBIOTIC RESISTANCE SWEDEN S LIFE SCIENCE STRATEGY ILLUSTRATION AJAK ARCHITECTS ALL

More information

PerkinElmer, Inc. JP Morgan Global Healthcare Conference. Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH

PerkinElmer, Inc. JP Morgan Global Healthcare Conference. Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH PerkinElmer, Inc JP Morgan Global Healthcare Conference Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH 2014 PerkinElmer FACTORS AFFECTING FUTURE PERFORMANCE & NON-GAAP

More information

Progress Report. Jouko Karvinen CEO of Medical Systems

Progress Report. Jouko Karvinen CEO of Medical Systems Progress Report Jouko Karvinen CEO of Medical Systems Forward Looking Statements Forward Looking Statements This document contains certain forward-looking statements with respect to the financial condition,

More information